| # | Drug | Count |
|---|---|---|
| 0 | EMPAGLIFLOZIN | 141 |
| 1 | METFORMIN | 125 |
| 2 | DAPAGLIFLOZIN | 118 |
| 3 | METFORMIN ER 500 MG | 105 |
| 4 | METFORMIN ER 750 MG | 105 |
| 5 | ASPIRIN | 75 |
| 6 | ASPIRIN 325 MG | 73 |
| 7 | ASPIRIN 81 MG | 73 |
| 8 | ACETAMINOPHEN | 63 |
| 9 | FUROSEMIDE | 62 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | SPARSENTAN | 31 | 0.0046 |
| 1 | EMPAGLIFLOZIN | 141 | 0.0020 |
| 2 | DAPAGLIFLOZIN | 118 | 0.0020 |
| 3 | CANAGLIFLOZIN | 57 | 0.0019 |
| 4 | ERGOCALCIFEROL | 46 | 0.0015 |
| 5 | ALEMTUZUMAB | 27 | 0.0014 |
| 6 | ROSUVASTATIN | 47 | 0.0005 |
| 7 | METHYLPREDNISOLONE SODIUM SUCCINATE | 21 | 0.0004 |
| 8 | GLIPIZIDE | 25 | 0.0004 |
| 9 | DULAGLUTIDE | 33 | 0.0004 |
| # | Drug class | Count |
|---|---|---|
| 0 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 191 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 150 |
| 2 | Corticosteroid [EPC] | 134 |
| 3 | Insulin Analog [EPC] | 102 |
| 4 | Angiotensin 2 Receptor Blocker [EPC] | 92 |
| 5 | GLP-1 Receptor Agonist [EPC] | 78 |
| 6 | Platelet Aggregation Inhibitor [EPC] | 76 |
| 7 | Loop Diuretic [EPC] | 75 |
| 8 | Benzodiazepine [EPC] | 71 |
| 9 | HMG-CoA Reductase Inhibitor [EPC] | 65 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | alpha-Glucosidase Inhibitor [EPC] | 10 | 0.0020 |
| 1 | Sodium-Glucose Cotransporter 2 Inhibitor [EPC] | 191 | 0.0018 |
| 2 | Provitamin D2 Compound [EPC] | 46 | 0.0015 |
| 3 | Hydrolytic Lysosomal Glycogen-specific Enzyme [EPC] | 5 | 0.0015 |
| 4 | CD52-directed Cytolytic Antibody [EPC] | 27 | 0.0014 |
| 5 | CD33-directed Immunoconjugate [EPC] | 5 | 0.0014 |
| 6 | Dipeptidyl Peptidase 4 Inhibitor [EPC] | 21 | 0.0006 |
| 7 | Glinide [EPC] | 5 | 0.0006 |
| 8 | Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 27 | 0.0005 |
| 9 | Insulin [EPC] | 23 | 0.0005 |